Stepwise Control of Crosslinking in a One‐Pot System for Bioprinting of Low‐Density Bioinks
Source abstract
Abstract
Abstract Extrusion‐based 3D bioprinting is hampered by the inability to print materials of low‐viscosity. In this study, a single initiating system based on ruthenium (Ru) and sodium persulfate (SPS) is utilized for a sequential dual‐step crosslinking approach: 1) primary (partial) crosslinking in absence of light to alter the bioink's rheological profile for print fidelity, and 2) subsequent secondary post‐printing crosslinking for shape maintenance. Allyl‐functionalized gelatin (Gel‐AGE) is used as a bioink, allowing thiol‐ene click reaction between allyl moieties and thiolated crosslinkers. A systematic investigation of primary crosslinking reveals that a thiol‐persulfate redox reaction facilitates thiol‐ene crosslinking, mediating an increase in bioink viscosity that is controllable by tailoring the Ru/SPS, crosslinker, and/or Gel‐AGE concentrations. Thereafter, subsequent photoinitiated secondary crosslinking then facilitates maximum conversion of thiol‐ene bonds between AGE and thiol groups. The dual‐step crosslinking method is applicable to a wide biofabrication window (3–10 wt% Gel‐AGE) and is demonstrated to allow printing of low‐density (3 wt%) Gel‐AGE, normally exhibiting low viscosity (4 mPa s), with high shape fidelity and high cell viability (>80%) over 7 days of culture. The presented approach can therefore be used as a one‐pot system for printing low‐viscous bioinks without the need for multiple initiating systems, viscosity enhancers, or complex chemical modifications.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Innovative Microfluidic and Catalytic Techniques Innovation · Neuroscience and Neural Engineering
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Christchurch Regenerative Medicine and Tissue Engineering (CReaTE) Group University of Otago 2 Riccarton Avenue Christchurch 8011 New Zealand
Medical Technologies Centre of Research Excellence Auckland 1010 New Zealand
Department for Functional Materials in Medicine and Dentistry (FMZ) and Bavarian Polymer Institute (BPI) University of Würzburg Pleicherwall 2 Würzburg 97070 Germany
Maurice Wilkins Centre for Molecular Biodiscovery Auckland 1010 New Zealand
Funding
Royal Society of New Zealand
References (59)
Show source-provided references
1. 10.1088/1758-5090/aaec5210.1088/1758-5090/aaec52 ↗
2. 10.1016/j.yexcr.2004.03.03510.1016/j.yexcr.2004.03.035 ↗
3. 10.22203/eCM.v035a2310.22203/eCM.v035a23 ↗
4. 10.1016/j.neures.2011.12.00510.1016/j.neures.2011.12.005 ↗
5. 10.1021/acs.chemrev.5b0030310.1021/acs.chemrev.5b00303 ↗
6. 10.1021/acsbiomaterials.6b0012110.1021/acsbiomaterials.6b00121 ↗
7. 10.1039/C4BM00070F10.1039/C4BM00070F ↗
8. 10.1021/acsbiomaterials.5b0043610.1021/acsbiomaterials.5b00436 ↗
9. 10.1002/adma.20170340410.1002/adma.201703404 ↗
10. 10.1007/s10439-016-1633-310.1007/s10439-016-1633-3 ↗
11. 10.1002/masy.20160017310.1002/masy.201600173 ↗
12. 10.1002/anie.20090392410.1002/anie.200903924 ↗
13. 10.1073/pnas.96.11.602010.1073/pnas.96.11.6020 ↗
14. 10.1016/S1074-5521(00)00020-X10.1016/S1074-5521(00)00020-X ↗
15. 10.1088/1758-5090/aac00c10.1088/1758-5090/aac00c ↗
16. 10.1002/mabi.20190009810.1002/mabi.201900098 ↗
17. 10.1088/1758-5090/ab19fd10.1088/1758-5090/ab19fd ↗
18. 10.1126/science.aau711410.1126/science.aau7114 ↗
19. 10.1002/marc.20120060510.1002/marc.201200605 ↗
20. 10.1016/j.freeradbiomed.2014.11.01310.1016/j.freeradbiomed.2014.11.013 ↗
21. 10.1021/acsbiomaterials.5b0042010.1021/acsbiomaterials.5b00420 ↗
22. 10.1080/0039791000808714610.1080/00397910008087146 ↗
23. 10.1002/macp.20170007310.1002/macp.201700073 ↗
24. 10.1021/acs.macromol.6b0160510.1021/acs.macromol.6b01605 ↗
25. 10.1021/ma970865610.1021/ma9708656 ↗
26. 10.1002/cctc.20100013710.1002/cctc.201000137 ↗
27. 10.1016/S1872-0854(10)04006-310.1016/S1872-0854(10)04006-3 ↗
28. 10.3390/gels403007210.3390/gels4030072 ↗
29. 10.1002/pola.2393310.1002/pola.23933 ↗
30. B. D.Fairbanks S. P.Singh C. N.Bowman K. S.Anseth 2011.
31. 10.1016/j.ab.2010.05.01110.1016/j.ab.2010.05.011 ↗
32. 10.1002/mabi.20120047110.1002/mabi.201200471 ↗
33. 10.1021/acsbiomaterials.6b0014910.1021/acsbiomaterials.6b00149 ↗
34. 10.1088/1758-5082/6/2/02410510.1088/1758-5082/6/2/024105 ↗
35. 10.1088/1758-5090/8/3/03500310.1088/1758-5090/8/3/035003 ↗
36. 10.1002/adma.20160498310.1002/adma.201604983 ↗
37. 10.1021/acschembio.7b0023710.1021/acschembio.7b00237 ↗
38. Lin C.‐C. · Biomaterials · 2011 · 32 · 85
39. 10.1016/j.biomaterials.2013.03.08610.1016/j.biomaterials.2013.03.086 ↗
40. 10.2307/357872710.2307/3578727 ↗
41. 10.1016/0891-5849(89)90147-010.1016/0891-5849(89)90147-0 ↗
42. 10.1016/S0300-483X(00)00331-010.1016/S0300-483X(00)00331-0 ↗
43. 10.1088/1758-5090/aa90e210.1088/1758-5090/aa90e2 ↗
44. 10.1088/1758-5090/aa8dd810.1088/1758-5090/aa8dd8 ↗
45. 10.1016/j.biomaterials.2014.02.04010.1016/j.biomaterials.2014.02.040 ↗
46. 10.1002/adhm.20150067710.1002/adhm.201500677 ↗
47. 10.1615/JLongTermEffMedImplants.201401094610.1615/JLongTermEffMedImplants.2014010946 ↗
48. 10.1002/smll.20190542110.1002/smll.201905421 ↗
49. L.Ouyang C. B.Highley C. B.Rodell W.Sun J. A.Burdick 2016.
50. 10.1002/smll.20140190610.1002/smll.201401906 ↗
51. 10.1126/sciadv.150075810.1126/sciadv.1500758 ↗
52. 10.1016/j.matlet.2016.12.12710.1016/j.matlet.2016.12.127 ↗
53. 10.1088/1758-5090/aadf5810.1088/1758-5090/aadf58 ↗
54. 10.22203/eCM.v022a0410.22203/eCM.v022a04 ↗
55. 10.1002/adma.20140507610.1002/adma.201405076 ↗
56. 10.1186/1477-3163-4-1110.1186/1477-3163-4-11 ↗
57. Gelatin Manufacturer's of America 2012 1.
58. 10.1002/mabi.20170015810.1002/mabi.201700158 ↗
59. 10.1038/labinvest.2011.7010.1038/labinvest.2011.70 ↗